Fulgent Genetics Inc
Fulgent Genetics (FLGT) is a clinical and research genetic testing company providing high‑throughput sequencing and molecular diagnostics across inherited disease, oncology and infectious disease testing. The firm operates centralised laboratories and a technology platform that automates sample processing, analysis and reporting. Revenue is generated from diagnostic test fees, research services and partnerships with biopharma and clinical laboratories. With a market capitalisation around USD 733.7m, it sits in the small‑to‑mid cap range and can offer growth exposure but also greater volatility. Key indicators investors watch include test volumes, reimbursement trends, lab utilisation and new test rollouts. Strengths include scalable infrastructure and a diversified service mix; principal risks include competition, changes in insurance reimbursement, regulatory scrutiny and variable public‑health testing demand. This is general educational information, not personal investment advice — suitability depends on your objectives and risk tolerance, and share values can fall as well as rise.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Fulgent Genetics' stock with a target price of $30, indicating growth potential.
Financial Health
Fulgent Genetics is performing well with strong revenue, solid cash flow, and a healthy profit margin.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring FLGT
The Alzheimer's Treatment Ecosystem
Following the EU regulator's approval of Eli Lilly's Alzheimer's drug, Kisunla, a new investment opportunity has emerged. This theme focuses on companies that provide essential support services, such as genetic testing and advanced imaging, which are crucial for the drug's administration and monitoring.
Published: July 27, 2025
Explore BasketDiagnostic Takeover Targets
This carefully selected group of stocks features innovative diagnostic companies that could become acquisition targets following recent takeover interest in the sector. Professional analysts have identified these companies for their unique technologies and established market positions in a consolidating healthcare landscape.
Published: July 15, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Growth Drivers
Investors may watch test volumes, new test launches and biopharma partnerships as potential sources of growth, though volumes can be cyclical and outcomes uncertain.
Technology & Scale
Scalable lab automation and data platforms can support margin improvement and capacity expansion, balanced by operational and regulatory execution risks.
Market Exposure
Primarily exposed to clinical testing demand and US reimbursement dynamics, with potential international or research‑service opportunities; reimbursement shifts can materially affect revenue.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Chemed Corp.
Provides hospice and palliative care services to patients facing life-limiting illness
Alignment Healthcare, Inc.
Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history.
Brookdale Senior Living Inc.
A leading owner and operator of senior living communities in the United States.
